FR2298832A1 - REGULATION PROCESS - Google Patents

REGULATION PROCESS

Info

Publication number
FR2298832A1
FR2298832A1 FR7601294A FR7601294A FR2298832A1 FR 2298832 A1 FR2298832 A1 FR 2298832A1 FR 7601294 A FR7601294 A FR 7601294A FR 7601294 A FR7601294 A FR 7601294A FR 2298832 A1 FR2298832 A1 FR 2298832A1
Authority
FR
France
Prior art keywords
regulation process
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7601294A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Original Assignee
Hospital for Sick Children HSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC filed Critical Hospital for Sick Children HSC
Publication of FR2298832A1 publication Critical patent/FR2298832A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7601294A 1975-01-22 1976-01-19 REGULATION PROCESS Withdrawn FR2298832A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA218,410A CA1040271A (en) 1975-01-22 1975-01-22 Artificial beta cell

Publications (1)

Publication Number Publication Date
FR2298832A1 true FR2298832A1 (en) 1976-08-20

Family

ID=4102116

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7601294A Withdrawn FR2298832A1 (en) 1975-01-22 1976-01-19 REGULATION PROCESS

Country Status (8)

Country Link
JP (1) JPS51125993A (en)
AU (1) AU1032476A (en)
CA (1) CA1040271A (en)
DE (1) DE2601893A1 (en)
FR (1) FR2298832A1 (en)
GB (1) GB1498332A (en)
IT (1) IT1053386B (en)
SE (1) SE7600588L (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409741A1 (en) * 1977-11-25 1979-06-22 Miles Lab APPARATUS FOR MONITORING GLUCOSE IN BLOOD
EP0027470A1 (en) * 1979-04-30 1981-04-29 Lichtenstein Eric Stefan Computer-controlled medical care system.
EP0032927A1 (en) * 1979-07-31 1981-08-05 Univ Rockefeller System for the controlled release of biologically active substances to a body fluid.
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
FR2557445A1 (en) * 1984-01-02 1985-07-05 Katsch G Zent Inst Diabetes METHOD AND DEVICE FOR THE AUTOMATIC PROSPECTIVE DETERMINATION OF INDIVIDUALLY SPECIFIC PARAMETERS OF GLUCOSE REGULATION
WO1987003814A1 (en) * 1985-12-20 1987-07-02 Schrezenmeir Juergen Device for continuous or discontinuous administration of insuline to the human body

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2737922A1 (en) * 1977-08-23 1979-03-08 Fresenius Chem Pharm Ind ARTIFICIAL ENDOCRINE DRUESE
JPS58198351A (en) * 1982-05-15 1983-11-18 株式会社京都第一科学 Method and apparatus for continuously measuring specific component in diluted liquid
JPS598969A (en) * 1982-07-09 1984-01-18 藤沢薬品工業株式会社 Artificial pancreas
FR2531333B1 (en) * 1982-08-09 1986-04-04 Centre Nat Rech Scient BIO-ARTIFICIAL PANCREAS WITH ULTRAFILTRATION
CA1254091A (en) * 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
GB8818690D0 (en) * 1988-08-05 1988-09-07 Red Kite Technology Ltd Refractive index measurement
US7037277B1 (en) 1998-07-21 2006-05-02 Spectrx, Inc. System and method for fluid management in a continuous fluid collection and sensor device
US7384396B2 (en) 1998-07-21 2008-06-10 Spectrx Inc. System and method for continuous analyte monitoring
AUPR632301A0 (en) * 2001-07-11 2001-08-02 Chee, Frederick Howe-Hui Infusion apparatus for regulating blood glucose levels
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
EP2695573B1 (en) * 2007-10-10 2021-04-28 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
WO2016134137A1 (en) 2015-02-18 2016-08-25 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
WO2017123525A1 (en) 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. User interface for diabetes management system
CN113101448B (en) 2016-01-14 2024-01-23 比格福特生物医药公司 System for adjusting insulin delivery rate
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
WO2018132765A1 (en) 2017-01-13 2018-07-19 Mazlish Bryan Insulin delivery methods, systems and devices
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
WO2020069406A1 (en) 2018-09-28 2020-04-02 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (en) 2018-10-11 2020-04-16 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4069082B1 (en) 2019-12-06 2024-06-05 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409741A1 (en) * 1977-11-25 1979-06-22 Miles Lab APPARATUS FOR MONITORING GLUCOSE IN BLOOD
EP0027470A1 (en) * 1979-04-30 1981-04-29 Lichtenstein Eric Stefan Computer-controlled medical care system.
EP0027470A4 (en) * 1979-04-30 1981-09-01 Lichtenstein Eric Stefan Computer-controlled medical care system.
EP0032927A1 (en) * 1979-07-31 1981-08-05 Univ Rockefeller System for the controlled release of biologically active substances to a body fluid.
EP0032927A4 (en) * 1979-07-31 1982-05-10 Univ Rockefeller System for the controlled release of biologically active substances to a body fluid.
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
FR2557445A1 (en) * 1984-01-02 1985-07-05 Katsch G Zent Inst Diabetes METHOD AND DEVICE FOR THE AUTOMATIC PROSPECTIVE DETERMINATION OF INDIVIDUALLY SPECIFIC PARAMETERS OF GLUCOSE REGULATION
WO1987003814A1 (en) * 1985-12-20 1987-07-02 Schrezenmeir Juergen Device for continuous or discontinuous administration of insuline to the human body

Also Published As

Publication number Publication date
AU1032476A (en) 1977-07-21
GB1498332A (en) 1978-01-18
JPS51125993A (en) 1976-11-02
CA1040271A (en) 1978-10-10
DE2601893A1 (en) 1976-07-29
IT1053386B (en) 1981-08-31
SE7600588L (en) 1976-07-23

Similar Documents

Publication Publication Date Title
FR2298832A1 (en) REGULATION PROCESS
FR2301555A1 (en) R PROCESS
FR2298596A1 (en) FA PROCESS
FR2301613A1 (en) PROCESS
FR2312113A1 (en) PICKLING PROCESS
FR2301288A1 (en) PROCESS P
FR2300291A1 (en) RE PROCESS
FR2300048A1 (en) PROCESS
FR2337120A1 (en) PROCESS D
FR2307833A1 (en) POLYPHENYLENE-ETHERS PREPARATION PROCESS
FR2299074A1 (en) PROCESS
FR2300812A1 (en) PROCESS
FR2301493A1 (en) PROCESS
BE839483A (en) AMMONOXIDATION PROCESS
FR2297709A1 (en) PREPARA PROCESS
FR2299421A1 (en) FUNCTIO PROCESS
BE839550A (en) INTEGRATED PROCESS
FR2311390A1 (en) TREATMENT PROCESS
FR2302333A1 (en) CONVERS PROCESS
FR2301966A1 (en) PROCESS
FR2297921A1 (en) R PROCESS
FR2301803A1 (en) PROCESS E
FR2327987A1 (en) 4-ALKYL-THIOSEMICARBAZIDES PREPARATION PROCESS
FR2300092A1 (en) PROCESS
BE843310A (en) DEHYDROCYCLODIMERIZATION PROCESS

Legal Events

Date Code Title Description
ST Notification of lapse